In human platelets, thrombin not only stimulates the phosphorylation of pleckstrin (P47) and of myosin P-light chains, but also induces the dephosphorylation of an 18-19 kDa phosphoprotein (P18) [Imaoka, Lynham and Haslam (1983) J. Biol. Chem. 258,[11404][11405][11406][11407][11408][11409][11410][11411][11412][11413][11414]. We have now studied this protein in detail. The thrombin-induced dephosphorylation reaction did not begin until the phosphorylation of myosin P-light chains and the secretion of dense-granule 5-hydroxytryptamine were nearly complete, but did parallel the later stages of platelet aggregation. Experiments with ionophore A23187 and phorbol 12-myristate 13-acetate indicated that dephosphorylation of P18 was stimulated by Ca2l, but not by protein kinase C. Two-dimensional analysis of platelet proteins, using non-equilibrium pH gradient electrophoresis followed by SDS/PAGE, showed that thrombin decreased the amount of phosphorylated P18 in platelets by up to 70% and slightly increased the amount of a more basic unlabelled protein that was present in 3-fold excess of P18 in INTRODUCTION
INTRODUCTION
Protein phosphorylation plays a major role in signal transduction following the activation of blood platelets by physiological stimuli [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Early studies with platelets that had been preincubated with [32P]Pi demonstrated that aggregating agents induce major increases in the 32P-labelling of proteins that migrate on SDS/PAGE at 40-47 kDa and 20 kDa [2] [3] [4] . The 40-47 kDa protein is the major platelet substrate of protein kinase C [5] and many studies have shown that its phosphorylation is associated with secretion of platelet granule constituents (e.g. [3, 6, 7] ). Although this protein, now named pleckstrin, has been purified [8] and cloned [9] , its precise function is still unclear. The 20 kDa group of phosphorylated proteins contains the P-light chains of platelet myosin [10] , phosphorylation of which may play a key role in the contractile events associated with platelet shape change [11] and possibly secretion [10, 12] . Three isoforms of the P-light chain exist in platelets and can often be resolved on SDS/PAGE as a 20 kDa doublet and a minor 19 kDa species [1, 13, 14] . These proteins are phosphorylated by both the Ca2+/calmodulin-dependent myosin light-chain kinase [15] and protein kinase C [14, 16] . In addition to these major increases in protein phosphorylation associated with platelet activation (and minor increases in the phosphorylation of multiple unidentified proteins [1, 8] ), one conspicuous phosphoprotein of 18-19 kDa (P18) present in resting platelets has been observed to undergo dephosphorylation after stimulation of platelets by collagen [1, 4] and particularly by thrombin [8] . To our knowledge, this protein has not been studied since these initial reports were published. We now show that P18 is unstimulated platelets. These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pHsensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin. The molar concentration of cofilin in platelets was approx. 10 % that of actin. Platelet cofilin was phosphorylated exclusively on serine. Experiments with electropermeabilized platelets showed that dephosphorylation of cofilin could be stimulated by guanosine 5'-[y-thio]triphosphate (GTP [S] ) in the absence of Ca2l or by a free Ca2+ concentration of 10 ,M. This GTP[S]-induced dephosphorylation reaction was inhibited by l-naphthyl phosphate, but not by okadaic acid. Our results add cofilin to the actin-binding proteins that may regulate the platelet cytoskeleton, and suggest that platelet cofilin can be activated by dephosphorylation reactions initiated either by a GTP-binding protein or Ca2 .
cofilin, a pH-sensitive actin-depolymerizing protein that binds to both G-and F-actin [17, 18] , and that about 25% of platelet cofilin is phosphorylated on serine in resting platelets. Experiments with permeabilized platelets showed that dephosphorylation of this protein could be initiated by independent guaninenucleotide-and Ca2l-dependent mechanisms. A preliminary report describing some of these findings has been published [19] . 13 %-acrylamide gels [8] . Proteins were stained with Coomassie Brilliant Blue R [4] ; in some experiments, the relative amounts of different proteins were determined by elution of the dye from the dried gels [20] . The 32p_ labelled proteins were detected by autoradiography [8] and, in some experiments, counted for 32P radioactivity [4] . Two-dimensional electrophoresis of platelet proteins Acid-precipitated protein was dissolved by sonication in a solution containing 9.5 M urea, 2 % (w/v) Nonidet P-40 and 2 % (v/v) mercaptoethanol and mixed with ampholytes (final concns. 1.5% Bio-Lyte 5/8 and 0.5% Bio-Lyte 3/10). Samples containing 0.5-1 mg of protein were subjected to non-equilibrium pH-gradient electrophoresis (NEpHGE) in 3 mm x 130 mm tube gels run at 1000 V for 1.6-2 h, as described in [21] . SDS/PAGE in the second dimension [8, 21] [22] . The fragments were resolved by SDS/PAGE, using a separating gel containing 16% acrylamide, and either stained with silver [23] and subjected to autoradiography, or electroblotted on to Immobilon-P8Q by using 10 mM CAPS buffer, pH 11, containing 20% (v/v) methanol [24] . [27] .
EXPERIMENTAL

Studies with electropermeabilized platelets
Platelets that had been labelled with [14C]5-HT were electropermeabilized and isolated by gel filtration in a medium (pH 7.4) containing 12.5 mM MgCl2 and the potassium salts of glutamic acid (160 mM), Hepes (20 mM), EGTA (2.5 mM) and EDTA (2.5 mM) (buffer A) [13] . After dilution to (3) (4) (5) [13] ) and a total of 10 ,1 of other additions in buffer A. Some incubation mixtures contained an additional 10 mM EGTA in place of CaCl2 to give an essentially Ca2+-free condition (pCa > 9) [29] . These mixtures were equilibrated for 15 min at 0°C and then incubated at 25°C, usually for 10 min, before measurement of the [14C]5-HT released into the medium [13] . Protein phosphorylation was determined in identical (100 ,u1) incubation mixtures, but permeabilized platelet suspension containing 16 ,Ci of [y-32P]ATP/sample [13] was used. Incubations were terminated by addition of 0.5 ml of 10 % (w/v) trichloroacetic acid, and the precipitated protein was analysed by SDS/PAGE in 13 %-acrylamide gels, followed by autoradiography of the dried gels.
RESULTS
Relationships between dephosphorylation of P18, secretion of dense-granule 5-HT and platelet aggregation When protein from platelets labelled with [32P]Pi was analysed by SDS/PAGE in 13 %-acrylamide gels, P18 was resolved as a welldefined 32P-labelled species that co-migrated with a distinct stained protein band [1] . By dye elution, we have now found that the mass amount of this protein present in platelets is equivalent to 6+ 1 % ofplatelet actin (mean + S.E.M., n = 5). In experiments in which 32P-labelled platelets were stirred with a high concentration of thrombin (1 unit/ml), a small initial increase in the labelling of P18 (at 5 s) was followed by a loss of 32P that was detected after 15 s and reached a maximum after 1 min (e.g. Figure 1 ). As determined by counting the 32P radioactivity in gel slices containing P18 (which could include small amounts of other labelled proteins of similar molecular mass), this maximum decrease in labelling averaged 42 + 4 % (mean + S.E.M., n = 4). The time course of P18 dephosphorylation differed markedly from that observed for the phosphorylation of the P-light chains of platelet myosin and the secretion of 5-HT, which were well under way only 5 s after addition of thrombin. However, the loss of 32P from P18 closely paralleled the later stages of platelet aggregation, measured as the decrease in attenuance of the platelet suspension ( Figure 1 ). P18 was detected with 0.1 unit of thrombin/ml and was optimal with 1 unit/ml, and at this time interval correlated with both platelet aggregation and the secretion of 5-HT (results not shown). Addition of neither 5 mM EGTA nor 5 mM EDTA affected the dephosphorylation of P18 measured 1 min after addition of thrombin at 1 unit/ml. Since EGTA decreased and EDTA abolished platelet aggregation (without affecting secretion of 5-HT), it follows that the dephosphorylation reaction is not an effect of platelet aggregation. Since signal transduction by thrombin involves synergistic effects mediated by the mobilization of Ca2+ and activation of protein kinase C [6, 7] , we examined the actions of ionophore A23187 and PMA, added alone or in combination, on the dephosphorylation of P18 (Figure 2 ). These experiments were carried out in the presence of indomethacin and an ADPscavenging enzyme system (creatine kinase and phosphocreatine) to prevent platelet activation by secondary mediators. Under these conditions, 0.2 #M A23187 caused a marked loss Of 32p from P18 by 1 min, at which time only small increases in the phosphorylation of the myosin P-light chains and pleckstrin were detected. These changes in protein phosphorylation were associated with platelet aggregation, but not with secretion of 5-HT ( Figure 2, lane 2) . In contrast, 100 nM PMA did not affect the 32P labelling of P18, but caused a marked increase in the phosphorylation of pleckstrin and a smaller increase in that of the myosin P-light chains (Figure 2, lane 3) . PMA alone did not induce significant platelet aggregation or secretion by 1 min, but in longer incubations (4 min, and especially 10 min) platelet aggregation was observed without dephosphorylation of P18. When added together, ionophore A23187 and PMA exerted potent synergistic effects on platelet aggregation and secretion, as initially reported by Yamanishi et al. [30] . This was associated with enhanced myosin phosphorylation, presumably reflecting the combined effects of myosin light-chain kinase [15] and protein kinase C [16] , whereas the observed changes in the phosphorylation of P18 and pleckstrin reflected the individual effects of A23187 and PMA respectively (Figure 2, lane 4) . These results show that loss of 32P from P18 can be mediated by Ca2+, but not by protein kinase C.
To establish that the loss of 32P reflects a decrease in the phosphorylation rather than just in the labelling of P18, platelet proteins were analysed by two-dimensional electrophoresis. Preliminary experiments established that P18 could only be resolved by NEpHGE/SDS/PAGE [20] , indicating that it is a much more basic protein than the myosin P-light chains [10, 14] . By this technique, three stained proteins with molecular masses close to that of P18 were detected ( Figure 3, proteins 1, 2 and 3) . Two of these (proteins 1 and 3) were unlabelled, whereas one (protein 2, P18) was a 32P-labelled species that showed marked decreases in both protein and radioactivity after treatment of platelets with thrombin ( Figure 3) . In these experiments, in which minor phosphorylated proteins could be excluded, the decrease in the 32P present in P18 amounted to 70+2% after incubation of labelled platelets for 3 min with 2 units of thrombin/ml (mean+S.E.M., n = 3). This loss of P18 was not accompanied by the appearance of a new more basic or a lower-molecular- mass protein species. However, small increases were usually detected in the staining of protein 1, which was more basic than protein 2 and present in much larger amounts (Figure 3) . These results suggested that the latter protein is either the dephosphorylated form of P18 (protein 2) or co-migrates with dephosphorylated P18. Elution of the dye from proteins 1 and 2 on three gels from each of two experiments indicated that, in each case, these proteins were present in a ratio of 3: 1 under resting conditions. Analyses of protein 2 (P18) for 32P-labelled phosphoamino acids [27] showed that all the label was in phosphoserine. Protein 1 (putative non-phosphorylated P18) and 32P-labelled protein 2 (P18) were separated by two-dimensional electrophoresis as in Figure 3 , proteolysed by endoproteinase Glu-C [22] and analysed by SDS/PAGE in 16%-acrylamide gels. Identlflcation of P18 Proteins 1 and 2 (see Figure 3) were compared by peptide mapping in one dimension (SDS/PAGE) after partial proteolysis with endoproteinase Glu-C, as described by Cleveland et al. [22] . Both proteins reproducibly yielded four major peptides ( Figure  4a ). For the non-phosphorylated species (protein 1), the apparent molecular masses of these peptides were 12.8 kDa (A), 10.7 kDa (B), 9.2 kDa (C) and 7.2 kDa (D). Protein 2 (P18), on the other hand, yielded two peptides similar in size to A and C (A' and C'), and two that migrated more slowly than B and D and contained 32p (B' and D') ( Figure 4b ). This result supports the idea that protein 1 is the dephosphorylated form of protein 2 (P18). Peptides A, B, C and D from protein 1 were electroblotted on to a poly(vinylidine fluoride) membrane and sequenced. Although both peptides B and D proved to be blocked at their N-termini, reliable sequence was obtained from peptide A (GKEILVGD-VGQTVDDPYATF) and peptide C (TKESKKEDLVFI). A computer search [31] of NCBI databases using the BLAST network service showed that these sequences are found only in pig [32] and human [33] cofilin, in which they follow glutamic in the first 51 residues of cofilin is phosphorylated in protein 2 (P18). To confirm our identification of proteins 1 and 2 as the nonphosphorylated and phosphorylated forms of cofilin, we used a monoclonal antibody to this protein (MAB-22) that does not react with destrin [26] . As shown by Western blotting (Figure 5 ), both proteins 1 and 2 were immunoreactive, whereas protein 3 was not. In some blots of NEpHGE/SDS/PAGE gels, a minor immunoreactive species that was not labelled with 32P was detected between proteins 1 and 2; this could be a second isoform of cofilin.
Factors affectng the dephosphorylatlon of P18 (cofliln) In permeabilized platelets
Previous work has shown that guanine nucleotides decrease the free Ca2+ concentration required to initiate secretion of granule constituents from electropermeabilized platelets [28] , and that 100 etM GTP[S] can induce some secretion in the effective absence of Ca2l (pCa > 9) [29] . Ca2`and GTP[S] also caused enhanced phosphorylation of the P-light chains of myosin and of pleckstrin in this system [13, 29] , as observed with thrombin in intact platelets. In the present study, we utilized permeabilized platelets to study the possible roles of guanine-nucleotide-dependent and Ca2+-dependent mechanisms in the dephosphorylation of P18. Little or no labelling of any platelet protein with 32P occurred during equilibration of permeabilized platelets with [y-32P]ATP at 0°C, but labelling of P18 was observed during incubation of the platelets at 25°C, either in the presence of low free Ca2+ concentrations (pCa 7 and 6 in Figure 6a, lanes 1 and 3) or in the absence of Ca2+ (pCa > 9 in Figures 6b and 6c) . In contrast, no labelling of P18 was observed during incubation of the platelets at pCa 5 ( Figure 6a, lane 5) . These results differ from those obtained for the myosin P-light chains, labelling of which was strikingly enhanced by Ca2+ (Figure 6a ). The labelling of the latter, which was marked at pCa 6, was more sensitive to Ca2+ than was the loss of label from P18, which required a pCa of 5.
Incubation of permeabilized platelets with GTP[S] not only increased 32P incorporation into pleckstrin and the P-light chains of myosin, but also markedly inhibited the labelling of P18, even in the effective absence of Ca2+ (Figures 6b and 6c) . To help to establish that GTP[S] caused dephosphorylation of P18, rather than an inhibition of its phosphorylation, P18 was labelled with 32P by preincubation of permeabilized platelets with [y-32P]ATP at 25°C before addition of GTP [S] . This led to a decrease in the extent of 5-HT secretion, probably as a result of resealing of the permeabilized platelets, but, as shown in Figure 6 (c), GTP[S] was still able to decrease the 32P labelling of P18 well below control values. In all the experiments with permeabilized platelets, the secretion of 5-HT in response to GTP[S], Ca2+ or both, correlated with the phosphorylation of the myosin P-light chains and with the loss of 32P from P18.
Addition of okadaic acid, an inhibitor of protein phosphatases 1 and 2A [35] , had no effect on the labelling of P18 in control incubations at pCa > 9 and failed to prevent the loss of 32P from this protein caused by either GTP[S] at pCa > 9 (Figure 6b) or by Ca2+ at pCa 5 (results not shown). Okadaic acid did, however, enhance both the phosphorylation of the P-light chains of myosin and the secretion of 5-HT caused by GTP[S] at pCa > 9. In contrast, a high (10 mM) concentration of a non-specific phosphatase inhibitor, l-naphthyl phosphate, which alone had no consistent effect on the labelling of P18 in permeabilized platelets incubated at pCa > 9, partly prevented the decrease in the labelling of P18 caused by GTP[S] (Figure 6b ). This was observed in each of three separate experiments, in which GTP[S] decreased Figure 6 platelets absence of 1-naphthyl phosphate and by 19 + 10 % in the presence of this phosphatase inhibitor (means+S.E.M.). Although 1-naphthyl phosphate enhanced the phosphorylation of the P-light chains of myosin, it differed from okadaic acid in that it inhibited the GTP[S]-induced secretion of (Figure 6b ). 1-Naphthyl phosphate did not prevent the loss of 32P from P18 observed when permeabilized platelets were incubated at pCa 5 (results not shown). To exclude the possibility that this Ca2+-dependent decrease in the labelling of P18 might result from the proteolytic action of calpain, we studied the effect of 0.2 mM leupeptin. Neither the labelling of P18 in the absence of Ca2+ nor the loss of 32P from P18 in platelets incubated at pCa 5 were influenced by this proteolytic inhibitor.
DISCUSSION
This investigation derives from early observations in this laboratory which showed that stimulation ofplatelets by aggregating agents, such as collagen and thrombin, led not only to major increases in the phosphorylation of some proteins, but also to dephosphorylation of an 18-19 kDa species that we termed P18 [1, 4, 8] . We have now shown that P18 is a phosphorylated form of the cytoskeletal protein cofilin, and that resting platelets contain both phosphorylated and dephosphorylated cofilin in a ratio of 1:3. The presence of these two forms of cofilin in platelets was established both by sequencing peptide fragments from these proteins after their isolation by two-dimensional electrophoresis and by immunoblotting with a specific monoclonal antibody to cofilin. Both methods clearly distinguished platelet cofilin from destrin, a closely related actindepolymerizing factor that is present in many of the same mammalian tissues but migrates on SDS/PAGE with a slightly lower apparent molecular mass [34] . To our knowledge, cofilin has not previously been reported in platelets.
Cofilin is a pH-sensitive actin-depolymerizing protein that can bind to both G-and F-actin [17, 18] . Although initial studies estimated the molecular mass of pig brain cofilin as 21 kDa [17] , molecular cloning gives a value of 18.5 kDa for the unprocessed protein [32] . Human cofilin differs from the pig protein only in the replacement of Cys-108 by Ser [33] . Three possible mechanisms have been suggested by which the F-actin-depolymerizing activity of cofilin might be regulated. The known pH-sensitivity of cofilin [18] implies that an increase in cellular pH above 7.3 could enhance actin depolymerization. However, the available evidence indicates that the intracellular pH does not increase above this level in stimulated platelets [36] . Second, the actindepolymerizing activity of cofilin is inhibited by polyphosphoinositides and phosphatidylinositol, which bind the protein and prevent its interaction with F-actin [37] . In this case, the lack of specificity of the interactions of cofilin with these phosphoinositides makes it unlikely that a change in their relative concentrations could regulate the action of cofilin. Third, there is increasing evidence that the phosphorylation status of cofilin can affect its biological activity. Thus, Ohta et al. [38] have reported that about 50 % of the cofilin in 3Y1 fibroblasts was phosphorylated on a serine residue and that exposure of these cells to heat shock or dimethyl sulphoxide led to dephosphorylation of the protein and its accumulation in the cell nucleus as actin/cofilin rods. In preliminary experiments, these workers have shown that, in vitro, cofilin can be phosphorylated by Ca2+/calmodulindependent protein kinase II and suggest that Ser-24 is the most likely phosphorylation site. This possibility is consistent with our conclusion that platelet cofilin is phosphorylated on serine in the depolymerizing factor, which is the avian homologue of destrin, have demonstrated the presence of the phosphorylated protein in myocytes and have shown that this form is unable to depolymerize actin [39] . If, as seems likely [39] , this finding can be extrapolated to mammalian cofilin, dephosphorylation of the platelet protein could generate additional cofilin with actindepolymerizing activity. This possibility is strongly supported by our preliminary experiments, in which gel filtration of platelet proteins on AcA 54 partly separated 32P-labelled cofilin from the dephosphorylated protein, which behaved as though it was bound to a larger protein, probably G-actin (M. M. L. Davidson and R. J. Haslam, unpublished work).
The relatively slow time course of cofilin dephosphorylation in intact platelets indicates that this process is not required for dense-granule secretion. Presumably, then, the quantitative correlation between secretion and dephosphorylation of cofilin in permeabilized platelets is coincidental. However, the time course of cofilin dephosphorylation did parallel the later stages of platelet aggregation and, as shown by our experiments with EDTA, is not an effect of aggregation itself. A role for the dephosphorylation of cofilin in platelet aggregation is thus conceivable, but is not easily reconciled with the ability of PMA to induce substantial aggregation without measurable dephosphorylation of the protein. In any case, it remains unclear whether newly formed dephosphorylated cofilin could have an important role in the cytoskeletal remodelling that occurs during platelet aggregation, since the net change is an increase in the F-actin content of the platelets [40] . Calculation suggests that the amount of dephosphorylated cofilin that becomes available during platelet aggregation is relatively small. As measured by the elution of dye from proteins separated by SDS/PAGE, cofilin was equivalent in mass to about 6 % of the platelet actin. Allowing for contaminating protein and the difference between the molecular masses of cofilin and actin, it follows that the molar concentration of cofilin in platelets is about 10 % of that of actin. Since only 25 % of this was phosphorylated in resting platelets and dephosphorylation by thrombin did not exceed 70 %, the newly available dephosphorylated cofilin is probably equivalent to no more than 1.5 % of the total platelet actin. For this to have a significant effect, dephosphorylation of cofilin would probably need to coincide with the release of other actinbinding proteins from F-actin. In this context, it is significant that cofilin has been shown to inhibit the interactions between Factin and tropomyosin, myosin or caldesmon [17, 41] .
The enzymes involved in the phosphorylation and dephosphorylation of platelet cofilin have not yet been characterized. Although it has been suggested that Ca2+/calmodulin-dependent protein kinase II may phosphorylate cofilin [38] , chick actindepolymerizing factor is a poor substrate for this enzyme [39] . Moreover, our results indicate that the phosphorylation of cofilin was not Ca2+-dependent in permeabilized platelets. Activation of protein kinase C by PMA did not increase the 32p labelling of cofilin (P18) or prevent dephosphorylation of this protein in intact platelets. Finally, increases in platelet cyclic AMP or cyclic GMP did not enhance the 32P labelling of P18 [1] . Our [43, 44] , both of which are inhibited by okadaic acid [35] . An additional okadaic acid-sensitive enzyme has also been described in platelets [44] . The Ca2l-dependent dephosphorylation of cofilin observed in both intact and permeabilized platelets in this study is consistent with a role for protein phosphatase 2B. However, the failure of okadaic acid to influence the GTP[S]-induced dephosphorylation reaction in permeabilized platelets, despite partial inhibition by the non-specific inhibitor 1-naphthyl phosphate, excludes protein phosphatases 1 and 2A from consideration. This suggests that GTP[S] must act either through the Mg2+-activated protein phosphatase 2C, of which there is little in platelets [45] , or on an as yet unidentified platelet protein phosphatase. There is a precedent for G-protein-mediated regulation of protein phosphatase activity, in that GTP [S] has been reported to inhibit myosin light-chain phosphatase in vascular smooth muscle [46] . In platelets, activation of a protein phosphatase by a GTP-binding protein could be direct or indirect. Thus, studies in this laboratory have shown that, in permeabilized platelets incubated in the absence of Ca2+, GTP[S] stimulates the formation of phosphatidic acid by phospholipase D, and have suggested that this phosphatidic acid may act as a second messenger that potentiates secretion [47] . Although GTP [S] slightly enhanced the phosphorylation of the P-light chains of myosin in permeabilized platelets incubated in the absence of Ca2 , this could reflect the activation of protein kinase C, possibly by phosphatidic acid [29, 47] , rather than an inhibition of a protein phosphatase [46] . 1-Naphthyl phosphate and okadaic acid both enhanced the control and GTP[S]-induced phosphorylation of myosin P-light chains in permeabilized platelets, but had opposite effects on the secretion of 5-HT. 1-Naphthyl phosphate inhibited the secretion of 5-HT from permeabilized platelets, although this compound has been reported to enhance secretion of noradrenaline from PC 12 cells [48] . Okadaic acid, on the other hand, potentiated the GTP[S]-induced secretion of 5-HT from permeabilized platelets, although it inhibits aggregation and secretion in intact platelets [45, 49] , probably because of inhibitory effects on Ca2+ mobilization [49] and phospholipase C activation [45] , which are not required for GTP[S]-induced secretion from permeabilized platelets [29, 47] .
